◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › 0-9 › 0719

Shandong Xinhua Pharmaceutical Company Limited (0719) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Shandong Xinhua Pharmaceutical Company Limited (0719) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Zibo, China with about 7,240 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 0719 reported CNY 8.8B in revenue and CNY 290M in net income.

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally.

Interactive charts & full statements →

0719 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total RevenueCNY 8.8BCNY 8.5BCNY 8.1BCNY 7.5B
Gross ProfitCNY 1.6BCNY 2.0BCNY 2.4BCNY 2.0B
Operating Income (EBIT)CNY 442MCNY 596MCNY 612MCNY 543M
Net IncomeCNY 290MCNY 470MCNY 496MCNY 411M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0719 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-06-302025-03-312024-12-31
Total RevenueCNY 2.4BCNY 2.0BCNY 2.2BCNY 2.4BCNY 1.7B
Gross ProfitCNY 441MCNY 348MCNY 474MCNY 456MCNY 459M
Operating Income (EBIT)CNY 133MCNY 57MCNY 180MCNY 146MCNY 141M
Net IncomeCNY 84MCNY 34MCNY 112MCNY 112MCNY 126M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0719 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-31
Dividends Paid(CNY 210M)(CNY 226M)(CNY 176M)(CNY 163M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0719 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-06-302025-03-312024-12-31
Dividends Paid(CNY 7M)(CNY 8M)(CNY 21M)(CNY 1M)(CNY 12M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0719 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total AssetsCNY 9.2BCNY 9.0BCNY 8.3BCNY 8.3B
Total LiabilitiesCNY 3.7BCNY 3.8BCNY 3.5BCNY 3.9B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0719 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← 0718All “0-9” companies0720 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.